EP 3221703 B1 20200527 - SIALYLATED FETUIN-A AS A MARKER OF IMMUNOTHERAPY EFFICACY
Title (en)
SIALYLATED FETUIN-A AS A MARKER OF IMMUNOTHERAPY EFFICACY
Title (de)
SIALYLIERTES FETUIN-A ALS MARKER DER IMMUNTHERAPIEEFFIZIENZ
Title (fr)
FETUINE-A SIALYLÉ EN TANT QUE MARQUEUR DE L'EFFICACITÉ DE L'IMMUNOTHÉRAPIE
Publication
Application
Priority
- EP 14306857 A 20141121
- EP 2015077360 W 20151123
Abstract (en)
[origin: WO2016079339A1] The invention concerns the identification of specific polypeptides, fragments variants thereof which can be used as markers for the efficacy of immunotherapy, particular for predicting responsiveness of a patient to immunotherapy.
IPC 8 full level
G01N 33/68 (2006.01)
CPC (source: EP US)
A61K 39/35 (2013.01 - US); C07K 14/4726 (2013.01 - EP US); C07K 14/473 (2013.01 - EP US); C07K 16/18 (2013.01 - US); C12N 15/115 (2013.01 - US); G01N 33/6893 (2013.01 - US); G01N 33/74 (2013.01 - EP US); A61K 2039/541 (2013.01 - US); C12N 2310/16 (2013.01 - US); G01N 2333/4728 (2013.01 - US); G01N 2333/71 (2013.01 - EP US); G01N 2400/10 (2013.01 - EP US); G01N 2440/38 (2013.01 - US); G01N 2560/00 (2013.01 - US); G01N 2800/24 (2013.01 - US); G01N 2800/52 (2013.01 - EP US)
Citation (examination)
CAROLINE CIENIEWSKI-BERNARD ET AL: "Identification of O- linked N -Acetylglucosamine Proteins in Rat Skeletal Muscle Using Two-dimensional Gel Electrophoresis and Mass Spectrometry", MOLECULAR & CELLULAR PROTEOMICS, vol. 3, no. 6, 1 June 2004 (2004-06-01), US, pages 577 - 585, XP055480018, ISSN: 1535-9476, DOI: 10.1074/mcp.M400024-MCP200
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2016079339 A1 20160526; EP 3221703 A1 20170927; EP 3221703 B1 20200527; ES 2813412 T3 20210323; US 10884002 B2 20210105; US 2017370946 A1 20171228
DOCDB simple family (application)
EP 2015077360 W 20151123; EP 15798420 A 20151123; ES 15798420 T 20151123; US 201515528250 A 20151123